So to do the efficacy and safety clinical trials t
Post# of 15624
What they want to do, of course, is be able to market and label the psoriasis cream with IRB and Helsinki safety and efficacy stamps/seals of approval.
IMHO, the cream will be ready to market as soon as efficacy and safety results are finalized. Everything else is literally in place already.